Structure

Physi-Chem Properties

Molecular Weight:  448.14
Volume:  430.209
LogP:  1.178
LogD:  0.657
LogS:  -1.885
# Rotatable Bonds:  8
TPSA:  162.98
# H-Bond Aceptor:  10
# H-Bond Donor:  5
# Rings:  3
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.355
Synthetic Accessibility Score:  3.943
Fsp3:  0.364
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.074
MDCK Permeability:  5.336883987183683e-06
Pgp-inhibitor:  0.003
Pgp-substrate:  0.04
Human Intestinal Absorption (HIA):  0.488
20% Bioavailability (F20%):  0.245
30% Bioavailability (F30%):  0.893

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.346
Plasma Protein Binding (PPB):  75.79693603515625%
Volume Distribution (VD):  1.071
Pgp-substrate:  15.582914352416992%

ADMET: Metabolism

CYP1A2-inhibitor:  0.102
CYP1A2-substrate:  0.079
CYP2C19-inhibitor:  0.068
CYP2C19-substrate:  0.071
CYP2C9-inhibitor:  0.045
CYP2C9-substrate:  0.823
CYP2D6-inhibitor:  0.399
CYP2D6-substrate:  0.572
CYP3A4-inhibitor:  0.063
CYP3A4-substrate:  0.095

ADMET: Excretion

Clearance (CL):  8.74
Half-life (T1/2):  0.796

ADMET: Toxicity

hERG Blockers:  0.055
Human Hepatotoxicity (H-HT):  0.469
Drug-inuced Liver Injury (DILI):  0.963
AMES Toxicity:  0.451
Rat Oral Acute Toxicity:  0.117
Maximum Recommended Daily Dose:  0.021
Skin Sensitization:  0.201
Carcinogencity:  0.121
Eye Corrosion:  0.003
Eye Irritation:  0.033
Respiratory Toxicity:  0.045

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC6985

Natural Product ID:  NPC6985
Common Name*:   2',4,6'-Trihydroxy-4'-Methoxydihydrochalcone 2'-O-Beta-D-Ribohexo-3-Ulopyranoside
IUPAC Name:   (2S,3S,5R,6R)-3,5-dihydroxy-2-[3-hydroxy-2-[3-(4-hydroxyphenyl)propanoyl]-5-methoxyphenoxy]-6-(hydroxymethyl)oxan-4-one
Synonyms:   Asebogenin 2'-O-beta-D-ribohexo-3-ulopyranoside
Standard InCHIKey:  NTMBWMBWUUMBLE-JHMKDJTOSA-N
Standard InCHI:  InChI=1S/C22H24O10/c1-30-13-8-15(26)18(14(25)7-4-11-2-5-12(24)6-3-11)16(9-13)31-22-21(29)20(28)19(27)17(10-23)32-22/h2-3,5-6,8-9,17,19,21-24,26-27,29H,4,7,10H2,1H3/t17-,19-,21-,22-/m1/s1
SMILES:  COc1cc(c(C(=O)CCc2ccc(cc2)O)c(c1)O[C@H]1[C@@H](C(=O)[C@@H]([C@@H](CO)O1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL482049
PubChem CID:   11247865
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13961 Pieris japonica Species Ericaceae Eukaryota n.a. leaf n.a. PMID[15787442]
NPO13961 Pieris japonica Species Ericaceae Eukaryota leaves n.a. n.a. PMID[15787442]
NPO13961 Pieris japonica Species Ericaceae Eukaryota Leaves n.a. n.a. PMID[31809052]
NPO13961 Pieris japonica Species Ericaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO13961 Pieris japonica Species Ericaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO13961 Pieris japonica Species Ericaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 16.41 10'-3cpm PMID[517569]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 35.0 10'-3cpm PMID[517569]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 34.21 10'-3cpm PMID[517569]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 32.04 10'-3cpm PMID[517569]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 26.73 10'-3cpm PMID[517569]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 38.28 10'-3cpm PMID[517569]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC6985 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9799 High Similarity NPC106625
0.9737 High Similarity NPC153342
0.9735 High Similarity NPC182634
0.9735 High Similarity NPC108831
0.9733 High Similarity NPC99233
0.9732 High Similarity NPC121001
0.9732 High Similarity NPC259182
0.9671 High Similarity NPC320283
0.9671 High Similarity NPC41121
0.9671 High Similarity NPC472459
0.9671 High Similarity NPC111929
0.9669 High Similarity NPC127406
0.9669 High Similarity NPC203500
0.9669 High Similarity NPC307938
0.9669 High Similarity NPC323593
0.9669 High Similarity NPC206378
0.961 High Similarity NPC27942
0.961 High Similarity NPC259834
0.961 High Similarity NPC131745
0.9608 High Similarity NPC187379
0.9605 High Similarity NPC135391
0.9605 High Similarity NPC78263
0.9605 High Similarity NPC23817
0.9605 High Similarity NPC197304
0.9605 High Similarity NPC133671
0.9605 High Similarity NPC77672
0.9605 High Similarity NPC54802
0.9605 High Similarity NPC43638
0.9603 High Similarity NPC97052
0.9603 High Similarity NPC95090
0.9603 High Similarity NPC27408
0.9603 High Similarity NPC72649
0.9603 High Similarity NPC169248
0.9603 High Similarity NPC26195
0.9603 High Similarity NPC39351
0.96 High Similarity NPC259767
0.96 High Similarity NPC88484
0.9548 High Similarity NPC183672
0.9548 High Similarity NPC179198
0.9548 High Similarity NPC66087
0.9548 High Similarity NPC278419
0.9545 High Similarity NPC476215
0.9545 High Similarity NPC249281
0.9545 High Similarity NPC246943
0.9545 High Similarity NPC259957
0.9545 High Similarity NPC253788
0.9545 High Similarity NPC139320
0.9545 High Similarity NPC282169
0.9545 High Similarity NPC173582
0.9545 High Similarity NPC276377
0.9545 High Similarity NPC129217
0.9545 High Similarity NPC159579
0.9545 High Similarity NPC48093
0.9545 High Similarity NPC116458
0.9545 High Similarity NPC181465
0.9545 High Similarity NPC163242
0.9545 High Similarity NPC215710
0.9545 High Similarity NPC473438
0.9545 High Similarity NPC224530
0.9545 High Similarity NPC265885
0.9545 High Similarity NPC216496
0.9545 High Similarity NPC85707
0.9542 High Similarity NPC73511
0.9539 High Similarity NPC170475
0.9536 High Similarity NPC210003
0.9536 High Similarity NPC83283
0.9536 High Similarity NPC39360
0.9536 High Similarity NPC143851
0.9536 High Similarity NPC29763
0.9484 High Similarity NPC150164
0.9484 High Similarity NPC240306
0.9481 High Similarity NPC136761
0.9481 High Similarity NPC304741
0.9481 High Similarity NPC246469
0.9481 High Similarity NPC142860
0.9481 High Similarity NPC97285
0.9481 High Similarity NPC471079
0.9481 High Similarity NPC271270
0.9481 High Similarity NPC470405
0.9477 High Similarity NPC156457
0.9477 High Similarity NPC65003
0.9477 High Similarity NPC60966
0.9477 High Similarity NPC161749
0.9477 High Similarity NPC197896
0.9477 High Similarity NPC473512
0.9477 High Similarity NPC44931
0.9477 High Similarity NPC313163
0.9477 High Similarity NPC288084
0.9477 High Similarity NPC258035
0.9477 High Similarity NPC129827
0.9467 High Similarity NPC477240
0.9467 High Similarity NPC214454
0.9467 High Similarity NPC106025
0.9467 High Similarity NPC191154
0.9463 High Similarity NPC199335
0.9423 High Similarity NPC121703
0.9419 High Similarity NPC470125
0.9419 High Similarity NPC135846
0.9419 High Similarity NPC64305
0.9419 High Similarity NPC170052
0.9419 High Similarity NPC303913
0.9419 High Similarity NPC297987
0.9416 High Similarity NPC308265
0.9416 High Similarity NPC104677
0.9416 High Similarity NPC138811
0.9416 High Similarity NPC473634
0.9416 High Similarity NPC22062
0.9412 High Similarity NPC149368
0.9412 High Similarity NPC45165
0.9412 High Similarity NPC265480
0.9408 High Similarity NPC268950
0.9408 High Similarity NPC108706
0.9408 High Similarity NPC211158
0.9408 High Similarity NPC78021
0.9408 High Similarity NPC87304
0.9404 High Similarity NPC190217
0.9404 High Similarity NPC134819
0.9396 High Similarity NPC176869
0.9396 High Similarity NPC211466
0.9396 High Similarity NPC44721
0.9396 High Similarity NPC40086
0.9396 High Similarity NPC122828
0.9396 High Similarity NPC3779
0.9396 High Similarity NPC23084
0.9396 High Similarity NPC476182
0.9363 High Similarity NPC72016
0.9363 High Similarity NPC139060
0.9363 High Similarity NPC287889
0.9363 High Similarity NPC135358
0.9359 High Similarity NPC190450
0.9359 High Similarity NPC44947
0.9359 High Similarity NPC127782
0.9359 High Similarity NPC300537
0.9355 High Similarity NPC473623
0.9355 High Similarity NPC271479
0.9355 High Similarity NPC200708
0.9355 High Similarity NPC472320
0.9351 High Similarity NPC122809
0.9346 High Similarity NPC470603
0.9346 High Similarity NPC470605
0.9346 High Similarity NPC470604
0.9338 High Similarity NPC213723
0.9308 High Similarity NPC270578
0.9308 High Similarity NPC5319
0.9308 High Similarity NPC52382
0.9304 High Similarity NPC256188
0.9304 High Similarity NPC476470
0.9304 High Similarity NPC12013
0.9304 High Similarity NPC11432
0.9304 High Similarity NPC32641
0.9304 High Similarity NPC64425
0.9304 High Similarity NPC189564
0.9304 High Similarity NPC221342
0.9304 High Similarity NPC142142
0.9304 High Similarity NPC477613
0.9304 High Similarity NPC203145
0.9304 High Similarity NPC186816
0.9299 High Similarity NPC257566
0.9299 High Similarity NPC124155
0.9299 High Similarity NPC80068
0.9295 High Similarity NPC101636
0.9295 High Similarity NPC47923
0.929 High Similarity NPC43761
0.9286 High Similarity NPC261866
0.9286 High Similarity NPC473657
0.9286 High Similarity NPC295613
0.9276 High Similarity NPC278476
0.9276 High Similarity NPC319910
0.9276 High Similarity NPC262038
0.9276 High Similarity NPC262039
0.9276 High Similarity NPC254412
0.9267 High Similarity NPC472918
0.9267 High Similarity NPC218685
0.9262 High Similarity NPC62290
0.9262 High Similarity NPC4152
0.9262 High Similarity NPC279417
0.9262 High Similarity NPC326506
0.9262 High Similarity NPC142731
0.9262 High Similarity NPC306607
0.9262 High Similarity NPC208176
0.9262 High Similarity NPC49130
0.9245 High Similarity NPC160156
0.9245 High Similarity NPC92565
0.9245 High Similarity NPC84362
0.9245 High Similarity NPC317489
0.9245 High Similarity NPC223424
0.9245 High Similarity NPC173637
0.9245 High Similarity NPC127546
0.9245 High Similarity NPC52550
0.9241 High Similarity NPC289667
0.9241 High Similarity NPC292929
0.9241 High Similarity NPC205824
0.9241 High Similarity NPC277205
0.9241 High Similarity NPC165720
0.9241 High Similarity NPC85751
0.9241 High Similarity NPC76831
0.9241 High Similarity NPC129264
0.9241 High Similarity NPC19240
0.9236 High Similarity NPC475382
0.9236 High Similarity NPC472876

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC6985 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9477 High Similarity NPD4381 Clinical (unspecified phase)
0.9308 High Similarity NPD7804 Clinical (unspecified phase)
0.9074 High Similarity NPD6797 Phase 2
0.9018 High Similarity NPD7251 Discontinued
0.9012 High Similarity NPD7074 Phase 3
0.9006 High Similarity NPD3818 Discontinued
0.8981 High Similarity NPD7075 Discontinued
0.8963 High Similarity NPD7808 Phase 3
0.8963 High Similarity NPD4338 Clinical (unspecified phase)
0.8951 High Similarity NPD7054 Approved
0.8896 High Similarity NPD7472 Approved
0.8846 High Similarity NPD6801 Discontinued
0.8839 High Similarity NPD4380 Phase 2
0.8792 High Similarity NPD1550 Clinical (unspecified phase)
0.8792 High Similarity NPD1552 Clinical (unspecified phase)
0.879 High Similarity NPD7096 Clinical (unspecified phase)
0.8765 High Similarity NPD6166 Phase 2
0.8765 High Similarity NPD6168 Clinical (unspecified phase)
0.8765 High Similarity NPD6167 Clinical (unspecified phase)
0.8758 High Similarity NPD4378 Clinical (unspecified phase)
0.8733 High Similarity NPD1549 Phase 2
0.8726 High Similarity NPD1934 Approved
0.8693 High Similarity NPD6799 Approved
0.8675 High Similarity NPD6559 Discontinued
0.8671 High Similarity NPD2393 Clinical (unspecified phase)
0.8526 High Similarity NPD5403 Approved
0.85 High Similarity NPD3817 Phase 2
0.8481 Intermediate Similarity NPD6599 Discontinued
0.8447 Intermediate Similarity NPD3882 Suspended
0.8438 Intermediate Similarity NPD2801 Approved
0.8428 Intermediate Similarity NPD7411 Suspended
0.8397 Intermediate Similarity NPD5401 Approved
0.8385 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8385 Intermediate Similarity NPD5402 Approved
0.8355 Intermediate Similarity NPD2796 Approved
0.8344 Intermediate Similarity NPD1512 Approved
0.8333 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8289 Intermediate Similarity NPD1510 Phase 2
0.828 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8267 Intermediate Similarity NPD1240 Approved
0.8229 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD1511 Approved
0.821 Intermediate Similarity NPD7819 Suspended
0.8176 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8158 Intermediate Similarity NPD1607 Approved
0.8025 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8024 Intermediate Similarity NPD6959 Discontinued
0.8 Intermediate Similarity NPD3751 Discontinued
0.7988 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7976 Intermediate Similarity NPD3787 Discontinued
0.7964 Intermediate Similarity NPD5494 Approved
0.7931 Intermediate Similarity NPD8313 Approved
0.7931 Intermediate Similarity NPD8312 Approved
0.7912 Intermediate Similarity NPD6780 Approved
0.7912 Intermediate Similarity NPD6777 Approved
0.7912 Intermediate Similarity NPD6779 Approved
0.7912 Intermediate Similarity NPD6776 Approved
0.7912 Intermediate Similarity NPD6781 Approved
0.7912 Intermediate Similarity NPD6778 Approved
0.7912 Intermediate Similarity NPD6782 Approved
0.7911 Intermediate Similarity NPD4628 Phase 3
0.7895 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.787 Intermediate Similarity NPD6232 Discontinued
0.7849 Intermediate Similarity NPD7584 Approved
0.7848 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7844 Intermediate Similarity NPD3749 Approved
0.7836 Intermediate Similarity NPD7473 Discontinued
0.7799 Intermediate Similarity NPD3750 Approved
0.7784 Intermediate Similarity NPD7768 Phase 2
0.7784 Intermediate Similarity NPD7435 Discontinued
0.7771 Intermediate Similarity NPD8455 Phase 2
0.7771 Intermediate Similarity NPD1551 Phase 2
0.7747 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD5844 Phase 1
0.7736 Intermediate Similarity NPD2800 Approved
0.773 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD7199 Phase 2
0.7688 Intermediate Similarity NPD7697 Approved
0.7688 Intermediate Similarity NPD7696 Phase 3
0.7688 Intermediate Similarity NPD7698 Approved
0.7683 Intermediate Similarity NPD1653 Approved
0.7673 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD1465 Phase 2
0.7662 Intermediate Similarity NPD6798 Discontinued
0.7657 Intermediate Similarity NPD5953 Discontinued
0.7651 Intermediate Similarity NPD1091 Approved
0.7647 Intermediate Similarity NPD7870 Phase 2
0.7647 Intermediate Similarity NPD7871 Phase 2
0.7644 Intermediate Similarity NPD7286 Phase 2
0.7637 Intermediate Similarity NPD6534 Approved
0.7637 Intermediate Similarity NPD6535 Approved
0.7628 Intermediate Similarity NPD1933 Approved
0.7622 Intermediate Similarity NPD920 Approved
0.7619 Intermediate Similarity NPD7701 Phase 2
0.7616 Intermediate Similarity NPD3926 Phase 2
0.7607 Intermediate Similarity NPD2532 Approved
0.7607 Intermediate Similarity NPD2534 Approved
0.7607 Intermediate Similarity NPD2533 Approved
0.7605 Intermediate Similarity NPD37 Approved
0.7595 Intermediate Similarity NPD7033 Discontinued
0.7588 Intermediate Similarity NPD6234 Discontinued
0.7586 Intermediate Similarity NPD7228 Approved
0.758 Intermediate Similarity NPD6651 Approved
0.7579 Intermediate Similarity NPD8151 Discontinued
0.7574 Intermediate Similarity NPD4966 Approved
0.7574 Intermediate Similarity NPD4965 Approved
0.7574 Intermediate Similarity NPD4967 Phase 2
0.7564 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD1613 Approved
0.7547 Intermediate Similarity NPD2935 Discontinued
0.7542 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7539 Intermediate Similarity NPD7874 Approved
0.7539 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7533 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD6832 Phase 2
0.7514 Intermediate Similarity NPD7699 Phase 2
0.7514 Intermediate Similarity NPD7700 Phase 2
0.7514 Intermediate Similarity NPD7685 Pre-registration
0.75 Intermediate Similarity NPD2344 Approved
0.75 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7783 Phase 2
0.75 Intermediate Similarity NPD1247 Approved
0.75 Intermediate Similarity NPD6233 Phase 2
0.75 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7801 Approved
0.75 Intermediate Similarity NPD8434 Phase 2
0.7485 Intermediate Similarity NPD919 Approved
0.7484 Intermediate Similarity NPD2799 Discontinued
0.7484 Intermediate Similarity NPD3748 Approved
0.7472 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD943 Approved
0.7451 Intermediate Similarity NPD1203 Approved
0.7447 Intermediate Similarity NPD6823 Phase 2
0.744 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD2313 Discontinued
0.7435 Intermediate Similarity NPD7585 Approved
0.7425 Intermediate Similarity NPD3226 Approved
0.7425 Intermediate Similarity NPD7458 Discontinued
0.7423 Intermediate Similarity NPD6190 Approved
0.7419 Intermediate Similarity NPD4908 Phase 1
0.7418 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD1652 Phase 2
0.7407 Intermediate Similarity NPD1243 Approved
0.7405 Intermediate Similarity NPD6355 Discontinued
0.7403 Intermediate Similarity NPD2798 Approved
0.7382 Intermediate Similarity NPD7583 Approved
0.7378 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD8320 Phase 1
0.7368 Intermediate Similarity NPD8319 Approved
0.7351 Intermediate Similarity NPD4360 Phase 2
0.7351 Intermediate Similarity NPD4363 Phase 3
0.7329 Intermediate Similarity NPD6099 Approved
0.7329 Intermediate Similarity NPD6100 Approved
0.7325 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD3268 Approved
0.7317 Intermediate Similarity NPD2309 Approved
0.7308 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD8150 Discontinued
0.7303 Intermediate Similarity NPD1610 Phase 2
0.7296 Intermediate Similarity NPD5124 Phase 1
0.7296 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD230 Phase 1
0.7289 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD2346 Discontinued
0.7284 Intermediate Similarity NPD7266 Discontinued
0.7267 Intermediate Similarity NPD1548 Phase 1
0.7261 Intermediate Similarity NPD3027 Phase 3
0.7255 Intermediate Similarity NPD9717 Approved
0.7244 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD2424 Discontinued
0.7226 Intermediate Similarity NPD2797 Approved
0.7222 Intermediate Similarity NPD7240 Approved
0.7212 Intermediate Similarity NPD2354 Approved
0.7212 Intermediate Similarity NPD3887 Approved
0.7205 Intermediate Similarity NPD7097 Phase 1
0.7204 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD6212 Phase 3
0.7204 Intermediate Similarity NPD6213 Phase 3
0.719 Intermediate Similarity NPD422 Phase 1
0.7188 Intermediate Similarity NPD447 Suspended
0.7186 Intermediate Similarity NPD4661 Approved
0.7186 Intermediate Similarity NPD4662 Approved
0.7175 Intermediate Similarity NPD2403 Approved
0.717 Intermediate Similarity NPD4062 Phase 3
0.7164 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD5710 Approved
0.7159 Intermediate Similarity NPD5711 Approved
0.7158 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD7390 Discontinued
0.7093 Intermediate Similarity NPD6844 Discontinued
0.7091 Intermediate Similarity NPD2654 Approved
0.7081 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD4308 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data